DM firm expands its West Coast office

Share this article:
Direct marketing solutions firm Structural Graphics has increased the size of its West Coast offices and added new personnel under a recent expansion.

In July, the firm moved from offices in Santa Monica, CA to larger digs in nearby Culver City.
“The old space didn't suit us any more,” said Michael Dambra VP, marketing Structural Graphics. “The new office is a larger space where we will be able to do more for our West Coast clients, independently from our headquarters in Essex, CT.”

Dambra said the firm has also added advertising and marketing veterans Bill May and Susanne Andrey to enhance its West Coast operations.

May joins as project manager from Dailey and Associates Advertising in West Hollywood, CA, where he worked for 17 years, most recently as VP and director of graphic services.

Andrey joins as account manager and was previously US sales and marketing manager for Button Group. There she worked closely with outside designers and printers to develop marketing materials for meeting planners, tourism boards and consumer product lines.

Structural Graphics also added Trusha Bhatt from Publicis to serve as internal sales partner, Dambra said.

According to Dambra, business has picked up for Structural Graphics in recent months, a result of doctors becoming less available to spend time with pharma sales reps.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?